Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A

被引:34
|
作者
Rasooly, Reuven [1 ]
Do, Paula M. [1 ]
机构
[1] ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA
关键词
D O I
10.1128/AEM.00617-08
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Currently, the only accepted assay with which to detect active Clostridium botulinum neurotoxin is an in vivo mouse bioassay. The mouse bioassay is sensitive and robust and does not require specialized equipment. However, the mouse bioassay is slow and not practical in many settings, and it results in the death of animals. Here, we describe an in vitro cleavage assay for SNAP-25 (synaptosome-associated proteins of 25 kDa) for measuring the toxin activity with the same sensitivity as that of the mouse bioassay. Moreover, this assay is far more rapid, can be automated and adapted to many laboratory settings, and has the potential to be used for toxin typing. The assay has two main steps. The first step consists of immunoseparation and concentration of the toxin, using immunomagnetic beads with monoclonal antibodies directed against the 100-kDa heavy chain subunit, and the second step consists of a cleavage assay targeting the SNAP-25 peptide of the toxin, labeled with fluorescent dyes and detected as a fluorescence resonance energy transfer assay. Our results suggest that the sensitivity of this assay is 10 pg/ml, which is similar to the sensitivity of the mouse bioassay, and this test can detect the activity of the toxin in carrot juice and beef. These results suggest that the assay has a potential use as an alternative to the mouse bioassay for analysis of C. botulinum type A neurotoxin.
引用
收藏
页码:4309 / 4313
页数:5
相关论文
共 50 条
  • [21] Transferability study of the BINACLE (binding and cleavage) assay for in vitro determination of botulinum neurotoxin activity
    Behrensdorf-Nicol, Heike A.
    Bonifas, Ursula
    Klimek, Jolanta
    Hanschmann, Kay-Martin
    Dorner, Brigitte G.
    Hohenadl, Christine
    Toellner, Lars
    Kegel, Birgit
    Kraemer, Beate
    BIOLOGICALS, 2020, 67 : 81 - 87
  • [22] Analysis of the Botulinum Neurotoxin Type F Gene Clusters in Proteolytic and Nonproteolytic Clostridium botulinum and Clostridium barati
    Alison K. East
    Manju Bhandari
    Sebastian Hielm
    Matthew D. Collins
    Current Microbiology, 1998, 37 : 262 - 268
  • [23] A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type E
    Chao, HY
    Wey, JJ
    Tang, SS
    Chen, A
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 268 - 268
  • [24] Production and purification of Clostridium botulinum type C and D neurotoxin
    Gessler, F
    Böhnel, H
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 24 (03): : 361 - 367
  • [25] Neurotoxin Gene Clusters in Clostridium botulinum Type Ab Strains
    Luquez, Carolina
    Raphael, Brian H.
    Maslanka, Susan E.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2009, 75 (19) : 6094 - 6101
  • [26] Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B
    Masuyer, Geoffrey
    Beard, Matthew
    Cadd, Verity A.
    Chaddock, John A.
    Acharya, K. Ravi
    JOURNAL OF STRUCTURAL BIOLOGY, 2011, 174 (01) : 52 - 57
  • [27] Immunochromatographic assay for determination of botulinum neurotoxin type D
    Klewitz, T
    Gessler, F
    Beer, H
    Pflanz, K
    Scheper, T
    SENSORS AND ACTUATORS B-CHEMICAL, 2006, 113 (02) : 582 - 589
  • [28] In Vitro Detection and Quantification of Botulinum Neurotoxin Type E Activity in Avian Blood
    Piazza, Timothy M.
    Blehert, David S.
    Dunning, F. Mark
    Berlowski-Zier, Brenda M.
    Zeytin, Fuesun N.
    Samuel, Michael D.
    Tucker, Ward C.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2011, 77 (21) : 7815 - 7822
  • [29] A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A
    Gregory, Richard W.
    Werner, William E.
    Ruegg, Curtis
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 69 (02) : 103 - 107
  • [30] Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors
    Masuyer, Geoffrey
    Davies, Jonathan R.
    Moore, Kevin
    Chaddock, John A.
    Acharya, K. Ravi
    SCIENTIFIC REPORTS, 2015, 5